{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:24:57Z","timestamp":1791347097777,"version":"4.3.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9-12","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.2119\/2004-00002.johansson","type":"journal-article","created":{"date-parts":[[2008,2,21]],"date-time":"2008-02-21T18:15:49Z","timestamp":1203617749000},"page":"193-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Biochemical Characterization of Porphobilinogen Deaminase-Deficient Mice During Phenobarbital Induction of Heme Synthesis and the Effect of Enzyme Replacement"],"prefix":"10.1186","volume":"9","author":[{"given":"Annika","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Fogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,5,30]]},"reference":[{"key":"9090193_CR1","first-page":"2991","volume":"2","author":"KE Anderson","year":"2001","unstructured":"Anderson KE, Sassa S, Bishop DF, Desnick RJ. (2001) Disorders of Heme Biosynthesis: X-Linked Sideroblastic Anemia and the Porphyrias. In: The Metabolic and Molecular Bases of Inherited Disease (Vol. 2). Scriver CR, Beaudet AL, Valle D, Sly WS (eds.). McGraw-Hill, New York, USA, pp. 2991\u20133062.","journal-title":"The Metabolic and Molecular Bases of Inherited Disease"},{"key":"9090193_CR2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0021-9258(18)96783-9","volume":"241","author":"S Granick","year":"1966","unstructured":"Granick S. (1966) The induction in vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: A response to certain drugs, sex hormones, and foreign chemicals. J. Biol. Chem. 241:1359\u201375.","journal-title":"J. Biol. Chem."},{"issue":"5","key":"9090193_CR3","first-page":"683","volume":"78","author":"K Miyagi","year":"1971","unstructured":"Miyagi K, Cardinal R, Bossenmaier I, Watson CJ. (1971) The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J. Lab. Clin. Med. 78(5):683\u201395.","journal-title":"J. Lab. Clin. Med."},{"key":"9090193_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/archinte.1954.00240260001001","volume":"93","author":"R Schmid","year":"1954","unstructured":"Schmid R, Schwartz S, Watson CJ. (1954) Porphyrin content of bone marrow and liver in the various forms of porphyria. AMA Arch. Int. Med. 93:167\u201390.","journal-title":"AMA Arch. Int. Med."},{"key":"9090193_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/brain\/93.2.369","volume":"93","author":"VP Sweeney","year":"1970","unstructured":"Sweeney VP, Pathak MA, Asbury AK. (1970) Acute intermittent porphyria. Increased ALA-synthetase activity during an acute attack. Brain. 93:369\u201380.","journal-title":"Brain"},{"key":"9090193_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0140-6736(54)90143-9","volume":"2","author":"A Goldberg","year":"1954","unstructured":"Goldberg A, Rimington C. (1954) Fate of porphobilinogen in the rat. Relation to acute porphyria in man. Lancet 2:172\u20133.","journal-title":"Lancet"},{"issue":"7","key":"9090193_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/003655100448310","volume":"60","author":"S Thunell","year":"2000","unstructured":"Thunell S. (2000) Porphyrins, porphyrin metabolism and porphyrias. I. Update. Scand. J. Clin. Lab. Invest. 60(7):509\u201340.","journal-title":"I. Update. Scand. J. Clin. Lab. Invest."},{"key":"9090193_CR8","first-page":"841","volume":"29","author":"EJH Bechara","year":"1996","unstructured":"Bechara EJH. (1996) Oxidative stress in acute intermittent porphyria and lead poisoning may be triggered by 5-aminolevulinic acid. Braz. J. Med. Biol. Res. 29:841\u201351.","journal-title":"Braz. J. Med. Biol. Res."},{"key":"9090193_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/07853899409147324","volume":"26","author":"R Kauppinen","year":"1994","unstructured":"Kauppinen R, Timonen K, Mustajoki P. (1994) Treatment of the porphyrias. Ann. Med. 26:31\u20138.","journal-title":"Ann. Med."},{"issue":"1","key":"9090193_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1055\/s-2007-1007140","volume":"18","author":"R Tenhunen","year":"1998","unstructured":"Tenhunen R, Mustajoki P. (1998) Acute porphyria: treatment with heme. Semin. Liver Dis. 18(1):53\u20135.","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"9090193_CR11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1742-1241.2002.tb11255.x","volume":"56","author":"MN Badminton","year":"2002","unstructured":"Badminton MN, Elder GH. (2002) Management of acute and cutaneous porphyrias. Int. J. Clin. Pract. 56(4):272\u20138.","journal-title":"Int. J. Clin. Pract."},{"key":"9090193_CR12","first-page":"23S","volume":"52","author":"E Sardh","year":"2003","unstructured":"Sardh E, Rejkjaer L, Harper P, Andersson DE. (2003) First clinical trial of i.v. rhPBGD in healthy subjects with and without diagnosed manifest acute intermittent porphyria (AIP). Physiol. Res. 52:23S.","journal-title":"Physiol. Res."},{"issue":"1","key":"9090193_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1432-1033.1987.tb10548.x","volume":"162","author":"B Grandchamp","year":"1987","unstructured":"Grandchamp B, De Verneuil H, Beaumont C, Chretien S, Walter O, Nordmann Y. (1987) Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene. Eur. J. Biochem. 162(1):105\u201310.","journal-title":"Eur. J. Biochem."},{"issue":"2","key":"9090193_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ng0296-195","volume":"12","author":"RL Lindberg","year":"1996","unstructured":"Lindberg RL et al. (1996) Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nat Genet. 12(2):195\u20139.","journal-title":"Nat Genet."},{"issue":"24","key":"9090193_CR15","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1046\/j.1432-1327.2000.01815.x","volume":"267","author":"R Jover","year":"2000","unstructured":"Jover R, Hoffmann F, Scheffler-Koch V, Lindberg RL. (2000) Limited heme synthesis in porphobilinogen deaminase-deficient mice impairs transcriptional activation of specific cytochrome P450 genes by phenobarbital. Eur. J. Biochem. 267(24):7128\u201337.","journal-title":"Eur. J. Biochem."},{"issue":"6","key":"9090193_CR16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood.V44.6.857.857","volume":"44","author":"CR Magnussen","year":"1974","unstructured":"Magnussen CR, Levine JB, Doherty JM, Cheesman JO, Tschudy DP (1974). A red cell enzyme method for the diagnosis of acute intermittent porphyria. Blood. 44(6):857\u201368.","journal-title":"Blood"},{"issue":"2","key":"9090193_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/003655102753611726","volume":"62","author":"A Johansson","year":"2002","unstructured":"Johansson A, M\u00f6ller C, Gellerfors P, Harper P. (2002) Non-viral mediated gene transfer of porphobilinogen deaminase into mammalian cells. Scand. J. Clin. Lab. Invest. 62(2):105\u201314.","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"9090193_CR18","first-page":"166","volume":"3","author":"C Lentner","year":"1984","unstructured":"Lentner C. (1984) Physical chemistry composition of blood hematology somatometric data. In: Geigy Scientific Tables (Vol. 3),Ciba-Geigy, pp. 166\u20137.","journal-title":"Geigy Scientific Tables"},{"key":"9090193_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/00039896.1967.10664873","volume":"15","author":"JR Davis","year":"1967","unstructured":"Davis JR, Andelman SL. (1967) Urinary delta-aminolevulinic acid (ALA) levels in lead poisoning. I. A modified method for the rapid determination of urinary delta-aminolevulinic acid using disposable ion-exchange chromatography columns. Arch. Envir. Health. 15:53\u20139.","journal-title":"Arch. Envir. Health."},{"key":"9090193_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/B978-0-12-262503-9.50019-0","volume":"III","author":"RM Bannerman","year":"1983","unstructured":"Bannerman RM. (1983) Hematology. In: The mouse in medical research (Vol. III). Foster HL, Small JD, Fox JG (eds.). Academic Press, Orlando, FL, USA, pp. 293\u2013312.","journal-title":"The mouse in medical research"},{"key":"9090193_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1084\/jem.143.2.305","volume":"143","author":"S Sassa","year":"1976","unstructured":"Sassa S. (1976) Sequential induction of heme pathway enzymes during erythroid differentiation of mouse friend leukemia virus-infected cells. J. Exp. Med. 143:305\u201315.","journal-title":"J. Exp. Med."},{"issue":"8","key":"9090193_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1172\/JCI5986","volume":"103","author":"RL Lindberg","year":"1999","unstructured":"Lindberg RL et al. (1999) Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria. J. Clin. Invest. 103(8):1127\u201334.","journal-title":"J. Clin. Invest."},{"key":"9090193_CR23","first-page":"10S","volume":"52","author":"P Harper","year":"2003","unstructured":"Harper P, Floderus Y, Andersson C, M\u00f6ller C, Rejkjaer L, Sardh E, Andersson DE. (2003) Correlation between plasma and urinary levels of porphobilinogen (PBG) and 5-aminolevulinic acid (ALA) in ten asymptomatic gene carriers of acute intermittent porphyria (AIP) with increased porphyrin precursor excretion. Physiol. Res. 52:10S.","journal-title":"Physiol. Res."},{"key":"9090193_CR24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/clinchem\/14.7.610","volume":"14","author":"I Bossenmaier","year":"1968","unstructured":"Bossenmaier I, Cardinal R. (1968) Stability of delta-aminolevulinic acid and porphobilinogen in urine under varying conditions. Clin. Chem. 14:610\u20134.","journal-title":"Clin. Chem."},{"issue":"2","key":"9090193_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0738-081X(97)00202-2","volume":"16","author":"GH Elder","year":"1998","unstructured":"Elder GH. (1998) Genetic defects in the porphyrias: types and significance. Clin. Dermatol. 16(2):225\u201333.","journal-title":"Clin. Dermatol."},{"issue":"4","key":"9090193_CR26","first-page":"179","volume":"33","author":"S Thunell","year":"1995","unstructured":"Thunell S et al. (1995) Markers for vulnerability in acute porphyria. A hypothesis paper. Eur. J. Clin. Chem. Clin. Biochem. 33(4):179\u201394.","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"9090193_CR27","first-page":"233","volume":"34","author":"E Dowdle","year":"1968","unstructured":"Dowdle E, Mustard P, Spong N, Eales L. (1968) The metabolism of [5-14C]delta-aminolaevulinic acid in normal and porphyric human subjects. Clin. Sci. 34: 233\u201351.","journal-title":"Clin. Sci."},{"issue":"6","key":"9090193_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1365-2362.1992.tb01482.x","volume":"22","author":"P Mustajoki","year":"1992","unstructured":"Mustajoki P, Timonen K, Gorchein A, Seppalainen AM, Matikainen E, Tenhunen R. (1992) Sustained high plasma 5-aminolaevulinic acid concentration in a volunteer: no porphyric symptoms. Eur. J. Clin. Invest. 22(6):407\u201311.","journal-title":"Eur. J. Clin. Invest."},{"key":"9090193_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0028-3908(84)90259-4","volume":"23","author":"SR Edwards","year":"1984","unstructured":"Edwards SR, Shanley BC, Reynoldson JA. (1984) Neuropharmacology of delta-aminolaevulinic acid-I. Effect of acute administration in rodents. Neuropharmacology 23:477\u201381.","journal-title":"Neuropharmacology"},{"key":"9090193_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1073\/pnas.68.2.383","volume":"68","author":"DS Feldman","year":"1971","unstructured":"Feldman DS, Levere RD, Lieberman JS, Cardinal RA, Watson CJ. (1971) Presynaptic neuromuscular inhibition by porphobilinogen and porphobilin. Proc. Nat. Acad. Sci. U.S.A. 68:383\u20136.","journal-title":"Proc. Nat. Acad. Sci. U.S.A."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.2119\/2004-00002.Johansson.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.2119\/2004-00002.Johansson\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.crossref.org\/2004-00002.Johansson","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/2004-00002.Johansson.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T11:03:30Z","timestamp":1708513410000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/2004-00002.Johansson"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":30,"journal-issue":{"issue":"9-12","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["9090193"],"URL":"https:\/\/doi.org\/10.2119\/2004-00002.johansson","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]},"assertion":[{"value":"27 January 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}